NCT07339813

Brief Summary

The MOTIF-STROKE study is embedded within the BrainSync project, aiming to develop innovative strategies for motor rehabilitation of the upper limb. The primary goal is to construct a high-resolution anatomo-functional disconnection atlas in a cohort of 100 stroke patients, using cutting-edge 3T and 7T MRI. Data acquisition, commencing in Fall 2025, will combine morphological (T1-weighted), functional and diffusion-weighted MRI scans to perform morphometry, functional and structural connectivity analyses with biomarkers of motor deficits. This atlas seeks to correlate connectivity with motor tasks, using dedicated task-related fMRI paradigms and digital consultation tools. The project utilizes machine learning algorithms and functional hyper-alignment to analyze fMRI data, focusing on input features and their impact on prediction accuracy. The ultimate objective is to optimize implantation of WIMAGINE neuroprostheses for the subsequent BCI4STROKE clinical trial. Expected results include identifying clinical subgroups responsive to motor intention decoding, characterizing phenotypes of functional reorganization, and making the 3D brain atlas accessible to the neuroscience community.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P75+ for not_applicable stroke

Timeline
32mo left

Started Dec 2025

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress15%
Dec 2025Jan 2029

Study Start

First participant enrolled

December 10, 2025

Completed
26 days until next milestone

First Submitted

Initial submission to the registry

January 5, 2026

Completed
9 days until next milestone

First Posted

Study publicly available on registry

January 14, 2026

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2027

Expected
1.2 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2029

Last Updated

January 14, 2026

Status Verified

December 1, 2025

Enrollment Period

1.9 years

First QC Date

January 5, 2026

Last Update Submit

January 5, 2026

Conditions

Keywords

motor disabilityfunctionnal MRIHigh-field MRIdisconnection atlasdiffusion-weighted MRImachine learning algorithms

Outcome Measures

Primary Outcomes (1)

  • Prediction accuracy of AI models for individual motor action intention

    Validation of AI model predictions based on post-processing of functional MRI signals will be performed by comparing them with observed clinical performance during intentional motor tasks. These include assessment of movement intention of the hand and foot, intended movement direction, pathological side, and healthy side.

    1 day

Study Arms (1)

Chronic-Phase Ischemic Stroke Patients and Healthy Volunteer Optimization

OTHER

Participants undergo task-based and resting-state fMRI sessions. Imaging and clinical data are collected and analyzed using artificial intelligence models.

Other: Functional MRI (fMRI) Acquisition

Interventions

Participants undergo task-based and resting-state fMRI sessions, including motor imagery and motor execution tasks. Brain activity and clinical data are collected for analysis.

Chronic-Phase Ischemic Stroke Patients and Healthy Volunteer Optimization

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients
  • Persistent upper-limb motor deficit resulting from the stroke.
  • Absence of significant cognitive impairment: MMSE score ≥ 27 assessed as part of clinical care.
  • Age between 18 and 70 years.
  • Signed informed consent after clear and fair information about the study.
  • Healthy volunteers:
  • Age between 18 and 70 years.
  • No history of neurological or psychiatric disease.
  • Signed informed consent after clear and fair information about the study.

You may not qualify if:

  • Patients:
  • Recurrent stroke.
  • Severe aphasia or severe speech disorders preventing adequate interaction for the protocol.
  • Severe auditory or visual impairment.
  • Disorders of comprehension, attention, or neglect affecting understanding of study motor tasks.
  • Associated conditions with an estimated life expectancy of less than 2 years.
  • History of brain surgery, craniectomy, or cranioplasty.
  • Other causes of motor disability.
  • Alcohol consumption the day before or on the day of the examination, or use of illicit psychotropic substances within 48 hours prior to MRI.
  • Absolute contraindications to MRI, including pregnancy; intracorporeal metallic foreign bodies; pacemakers; non-MRI-compatible neurostimulators; cochlear implants; implanted medical devices (electronic or non-electronic) implanted for less than 6 weeks; metallic heart valves; stents, coils, carotid or neurosurgical clips; implantable ports; infusion pumps; non-removable piercings; tattoos or permanent makeup larger than 5 cm on the head, neck, trunk, or upper limbs; transdermal devices with metallic components; intrauterine devices (except Mirena); dental appliances larger than 4 cm; or health conditions incompatible with MRI comfort and safety (e.g., acute respiratory or cardiac failure, inability to remain supine, bedridden state, claustrophobia).
  • Individuals not covered by a social security system.
  • Individuals under enhanced protection, including pregnant or breastfeeding women, persons deprived of liberty, legally protected adults, or patients in emergency situations.
  • Pregnant or breastfeeding women, or women of childbearing potential refusing a pregnancy test.
  • Healthy volunteer:
  • Absolute contraindications to MRI as listed above.
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

NeuroSpin, CEA

Gif-sur-Yvette, Île-de-France Region, 91191, France

RECRUITING

MeSH Terms

Conditions

Stroke

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Myriam Edjlali-Goujon, MD, PhD

    Commissariat A L'energie Atomique

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: RIPH 2
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

January 5, 2026

First Posted

January 14, 2026

Study Start

December 10, 2025

Primary Completion (Estimated)

November 1, 2027

Study Completion (Estimated)

January 1, 2029

Last Updated

January 14, 2026

Record last verified: 2025-12

Locations